MEMBRANOUS NEPHROPATHY WITH SEVERE TUBULOINTERSTITIAL AND VASCULAR CHANGES IN A PATIENT WITH PSORIATIC-ARTHRITIS TREATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS

被引:0
|
作者
GRCEVSKA, L
POLENAKOVIC, M
FERLUGA, D
VIZJAK, A
STAVRIC, G
机构
[1] FAC MED SKOPJE,INST ONCOL & RADIOTHERAPY,SKOPJE,MACEDONIA
[2] FAC MED LJUBLJANA,CTR CLIN,INST PATHOL,LJUBLJANA,SLOVENIA
关键词
MEMBRANOUS NEPHROPATHY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PSORIATIC ARTHRITIS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report on a patient who suffered from psoriasis vulgaris and psoriatic arthritis and developed nephrotic syndrome after long-term therapy with non-steroidal anti-inflammatory drugs. Membranous nephropathy with tubulointerstitial and vascular (intimal hyperplasia) changes was found on renal biopsy using optical, immunofluorescent and electron microscopy. Treatment with methylprednisolone ''pulse'' therapy (1 g/24 h during 3 days) and continuing with prednisone 0,5 mg/kg/24 h was ineffective and end-stage renal failure developed 6 months after the diagnosis had been established.
引用
收藏
页码:250 / 253
页数:4
相关论文
共 27 条
  • [21] Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer:A case report
    Sehan Kim
    Jong Hee Sun
    Hongsik Kim
    Hee Kyung Kim
    Yaewon Yang
    Jun Su Lee
    In Ah Choi
    Hye Sook Han
    World Journal of Clinical Cases, 2023, (01) : 218 - 224
  • [22] Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report
    Kim, Sehan
    Sun, Jong Hee
    Kim, Hongsik
    Kim, Hee Kyung
    Yang, Yaewon
    Lee, Jun Su
    Choi, In Ah
    Han, Hye Sook
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (01) : 218 - 224
  • [23] Changes in Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Ixekizumab in a Real-World US Cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Sprabery, Aubrey
    Lubrano, Ennio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 750 - 752
  • [24] CHANGES IN DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH IXEKIZUMAB IN A REAL-WORLD US COHORT
    Birt, J.
    Tillett, W.
    Cavanaugh, C.
    Jung, Y.
    Vadhariya, A.
    Ross, S.
    Paulus, J.
    Sprabery, A. T.
    Lubrano, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 851 - 852
  • [25] Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs—a primary or secondary entity?
    Ewa Więsik-Szewczyk
    Aleksandra Kucharczyk
    Katarzyna Świerkocka
    Elżbieta Rutkowska
    Karina Jahnz-Różyk
    Clinical Rheumatology, 2017, 36 : 1677 - 1681
  • [26] Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?
    Wiesik-Szewczyk, Ewa
    Kucharczyk, Aleksandra
    Swierkocka, Katarzyna
    Rutkowska, Elzbieta
    Jahnz-Rozyk, Karina
    CLINICAL RHEUMATOLOGY, 2017, 36 (07) : 1677 - 1681
  • [27] Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Lubrano, Ennio
    FRONTIERS IN MEDICINE, 2023, 10